Cargando…

Application of oxycodone in anesthesia induction and overall management of Da Vinci robot-assisted nephrectomy: A randomized controlled trial

BACKGROUND: This study aimed to evaluate the application of oxycodone in anesthesia induction and overall management of Da Vinci robot-assisted nephrectomy. METHODS: A total of 42 patients undergoing Da Vinci robot-assisted nephrectomy with general anesthesia were selected. They were randomly divide...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haihong, Qiu, Yuanli, Zheng, Qiang, Chen, Yijiao, Ma, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371572/
https://www.ncbi.nlm.nih.gov/pubmed/35960116
http://dx.doi.org/10.1097/MD.0000000000029893
_version_ 1784767182930968576
author Wang, Haihong
Qiu, Yuanli
Zheng, Qiang
Chen, Yijiao
Ma, Liang
author_facet Wang, Haihong
Qiu, Yuanli
Zheng, Qiang
Chen, Yijiao
Ma, Liang
author_sort Wang, Haihong
collection PubMed
description BACKGROUND: This study aimed to evaluate the application of oxycodone in anesthesia induction and overall management of Da Vinci robot-assisted nephrectomy. METHODS: A total of 42 patients undergoing Da Vinci robot-assisted nephrectomy with general anesthesia were selected. They were randomly divided into 2 groups: patients were induced with oxycodone (oxycodone group) and were induced with sufentanil (sufentanil group). The vital signs at the following time points were recorded: after injection of induced drugs (T1), during glottis exposure (T2), immediately after intubation (T3), 1 minute (T4), 2 minute (T5), 3 minute (T6), 5 minute (T7), 10 minute (T8) after intubation, during skin incision (T9), at the end of suturing skin (T10), during extubation (T11), and during hemodynamic fluctuations intraoperatively (T`). Numerical rating scale, facial affective scale and monitoring of adverse events (visual analogue scale, NVAS) were evaluated postoperatively at 1 hour (T’“1), 3 hours (T”“2), 6 hours (T”“3), 12 hours (T”“4), 24 hours (T”“5), and 48 hours (T”‘6). RESULTS: The systolic blood pressure, the diastolic blood pressure and the mean arterial blood pressure showed no statistically different changes between the 2 groups. There were no statistical differences in heart rate and respiratory rate among various timepoints intraoperatively. There were statistical differences in Bispectral index (BIS) scores in T6 between the 2 groups. The numerical rating scale and facial affective scale scores were significantly lower in oxycodone group. Anesthetized with oxycodone, the pain did not affect the sleep of patients after operation. Also, the postoperative QoR-40 scores were lower in oxycodone group. CONCLUSION: Compared with sufentanil, anesthesia induction with 0.3 mg/kg oxycodone in Da Vinci robot-assisted nephrectomy can achieve mild pain and mild adverse responses in patients postoperatively.
format Online
Article
Text
id pubmed-9371572
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-93715722022-08-16 Application of oxycodone in anesthesia induction and overall management of Da Vinci robot-assisted nephrectomy: A randomized controlled trial Wang, Haihong Qiu, Yuanli Zheng, Qiang Chen, Yijiao Ma, Liang Medicine (Baltimore) Research Article BACKGROUND: This study aimed to evaluate the application of oxycodone in anesthesia induction and overall management of Da Vinci robot-assisted nephrectomy. METHODS: A total of 42 patients undergoing Da Vinci robot-assisted nephrectomy with general anesthesia were selected. They were randomly divided into 2 groups: patients were induced with oxycodone (oxycodone group) and were induced with sufentanil (sufentanil group). The vital signs at the following time points were recorded: after injection of induced drugs (T1), during glottis exposure (T2), immediately after intubation (T3), 1 minute (T4), 2 minute (T5), 3 minute (T6), 5 minute (T7), 10 minute (T8) after intubation, during skin incision (T9), at the end of suturing skin (T10), during extubation (T11), and during hemodynamic fluctuations intraoperatively (T`). Numerical rating scale, facial affective scale and monitoring of adverse events (visual analogue scale, NVAS) were evaluated postoperatively at 1 hour (T’“1), 3 hours (T”“2), 6 hours (T”“3), 12 hours (T”“4), 24 hours (T”“5), and 48 hours (T”‘6). RESULTS: The systolic blood pressure, the diastolic blood pressure and the mean arterial blood pressure showed no statistically different changes between the 2 groups. There were no statistical differences in heart rate and respiratory rate among various timepoints intraoperatively. There were statistical differences in Bispectral index (BIS) scores in T6 between the 2 groups. The numerical rating scale and facial affective scale scores were significantly lower in oxycodone group. Anesthetized with oxycodone, the pain did not affect the sleep of patients after operation. Also, the postoperative QoR-40 scores were lower in oxycodone group. CONCLUSION: Compared with sufentanil, anesthesia induction with 0.3 mg/kg oxycodone in Da Vinci robot-assisted nephrectomy can achieve mild pain and mild adverse responses in patients postoperatively. Lippincott Williams & Wilkins 2022-08-12 /pmc/articles/PMC9371572/ /pubmed/35960116 http://dx.doi.org/10.1097/MD.0000000000029893 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Wang, Haihong
Qiu, Yuanli
Zheng, Qiang
Chen, Yijiao
Ma, Liang
Application of oxycodone in anesthesia induction and overall management of Da Vinci robot-assisted nephrectomy: A randomized controlled trial
title Application of oxycodone in anesthesia induction and overall management of Da Vinci robot-assisted nephrectomy: A randomized controlled trial
title_full Application of oxycodone in anesthesia induction and overall management of Da Vinci robot-assisted nephrectomy: A randomized controlled trial
title_fullStr Application of oxycodone in anesthesia induction and overall management of Da Vinci robot-assisted nephrectomy: A randomized controlled trial
title_full_unstemmed Application of oxycodone in anesthesia induction and overall management of Da Vinci robot-assisted nephrectomy: A randomized controlled trial
title_short Application of oxycodone in anesthesia induction and overall management of Da Vinci robot-assisted nephrectomy: A randomized controlled trial
title_sort application of oxycodone in anesthesia induction and overall management of da vinci robot-assisted nephrectomy: a randomized controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371572/
https://www.ncbi.nlm.nih.gov/pubmed/35960116
http://dx.doi.org/10.1097/MD.0000000000029893
work_keys_str_mv AT wanghaihong applicationofoxycodoneinanesthesiainductionandoverallmanagementofdavincirobotassistednephrectomyarandomizedcontrolledtrial
AT qiuyuanli applicationofoxycodoneinanesthesiainductionandoverallmanagementofdavincirobotassistednephrectomyarandomizedcontrolledtrial
AT zhengqiang applicationofoxycodoneinanesthesiainductionandoverallmanagementofdavincirobotassistednephrectomyarandomizedcontrolledtrial
AT chenyijiao applicationofoxycodoneinanesthesiainductionandoverallmanagementofdavincirobotassistednephrectomyarandomizedcontrolledtrial
AT maliang applicationofoxycodoneinanesthesiainductionandoverallmanagementofdavincirobotassistednephrectomyarandomizedcontrolledtrial